SAI Life Sciences Ltd Executive and Leadership Team

Ravi Badgi, the Chief Executive Officer at SAI Life Sciences Ltd, directs the overarching corporate strategy and long-term growth initiatives. Overseeing the integration of synthetic and medicinal chemistry services, the Chief Executive Officer ensures alignment between internal research capabilities and the evolving needs of global pharmaceutical clients. This leadership role involves optimizing operational efficiency across all drug discovery platforms to maintain a competitive edge in the biotechnology sector. By fostering cross-functional collaboration, Badgi drives the expansion of service offerings into new therapeutic areas. The Chief Executive Officer also manages high-level stakeholder relationships, ensuring that the company remains a preferred partner for complex NCE formulation projects. Through strategic resource allocation, Ravi Badgi secures the necessary infrastructure to support large-scale manufacturing demands. Ultimately, Badgi maintains the company's reputation for scientific excellence and operational reliability within the international life sciences market.

Krishna Kanumuri, the Chief Executive Officer & Managing Director at SAI Life Sciences Ltd, governs the strategic direction and executive management of the entire organization. Focusing on the expansion of generic formulation development and re-formulation services, the Chief Executive Officer & Managing Director oversees the company's broad market reach across international territories. This leadership role involves guiding the board through complex investment decisions and ensuring the sustainability of the business model. By prioritizing innovation in biology services, Kanumuri drives the company toward achieving significant milestones in drug development. The Chief Executive Officer & Managing Director also monitors the performance of various business units to ensure consistent revenue growth and operational excellence. Through the implementation of robust governance frameworks, Krishna Kanumuri maintains high standards of corporate integrity. Ultimately, Kanumuri shapes the long-term vision for the organization, positioning the firm as a leader in the global pharmaceutical services landscape.

Maneesh Pingle, the President, Discovery at SAI Life Sciences Ltd, leads the scientific strategy and execution of all drug discovery and biology service offerings. Overseeing a team of expert researchers, the President, Discovery ensures that the company remains at the forefront of medicinal chemistry and pre-formulation innovation. This leadership role involves identifying emerging trends in the biotechnology industry and adapting the company's research capabilities to meet client requirements. By fostering a culture of scientific rigor, Pingle drives the development of novel therapeutic candidates and enhances the company's intellectual property portfolio. The President, Discovery also collaborates with other C-suite leaders to align research objectives with the broader commercial goals of the organization. Through the management of high-impact research programs, Maneesh Pingle secures the company's position as a premier partner for early-stage drug development. Ultimately, Pingle delivers the scientific breakthroughs that define the company's market impact.

Gautham Manoj, the Chief of Staff at SAI Life Sciences Ltd, coordinates executive operations and facilitates seamless communication across all internal departments. Overseeing the execution of strategic projects, the Chief of Staff ensures that organizational goals align with the company's mission of providing high-quality drug discovery services. This leadership role involves managing the flow of information to the executive team and optimizing internal processes to improve productivity. By streamlining administrative workflows, Manoj supports the leadership in making data-driven decisions regarding pre-formulation and development services. The Chief of Staff also acts as a liaison between various functional heads, fostering a culture of transparency and accountability. Through the management of key corporate initiatives, Gautham Manoj enhances the overall agility of the organization. Ultimately, Manoj ensures that the executive office functions efficiently, allowing the company to focus on delivering superior scientific solutions to biotechnology partners.

Khursheed Syed, the Chief of Staff - CMC at SAI Life Sciences Ltd, manages the operational complexities associated with chemical manufacturing and control processes. Overseeing the technical integration of manufacturing services, the Chief of Staff - CMC ensures that all production activities meet stringent quality and regulatory standards. This leadership role involves coordinating between the chemistry teams and the manufacturing units to optimize the transition from drug discovery to commercial production. By implementing advanced process controls, Syed drives improvements in efficiency and yield for complex pharmaceutical projects. The Chief of Staff - CMC also monitors the performance of manufacturing facilities to ensure consistent output and adherence to safety protocols. Through the oversight of technical resources, Khursheed Syed supports the company's ability to handle large-scale generic formulation development. Ultimately, Syed ensures that the manufacturing division remains a core pillar of the company's service portfolio.